Skip to main content
British Heart Journal logoLink to British Heart Journal
. 1985 Oct;54(4):351–356. doi: 10.1136/hrt.54.4.351

Effect of early treatment with propranolol on left ventricular function four weeks after myocardial infarction.

M A Brown, R M Norris, P F Barnaby, G G Geary, P W Brandt
PMCID: PMC481909  PMID: 4052276

Abstract

Left ventricular function and exercise capacity were assessed in 79 patients randomised to receive intravenous and oral propranolol (n = 44) or conventional therapy (n = 35) within four hours of onset of their first myocardial infarction. Cineangiocardiography and exercise testing were performed four weeks after infarction to allow for maximum recovery of myocardial function. Left ventriculography showed no improvement in ejection fraction or preservation of regional contractile function in patients treated with propranolol compared with controls. A trend towards smaller end diastolic volumes was seen in the propranolol group (mean (SD) 151(42) ml) compared with controls (167(42) ml). Exercise duration and frequency of angina were not significantly different in the two groups. It is concluded that limitation of infarct size by propranolol does not lead to a significant improvement in ventricular systolic function, although left ventricular dilatation may be reduced. These findings are consistent with the known effect of early intravenous beta blockade which limits infarct size by preservation of subepicardial myocardium.

Full text

PDF
351

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Azancot I., Lorente P., Georgiopoulos G., Beaufils P., Masquet C., Baudouy Y., Slama R. Effects of acebutolol on myocardial infarct extension: a randomized electrocardiographic, enzymatic and angiographic study. Circulation. 1982 Nov;66(5):986–994. doi: 10.1161/01.cir.66.5.986. [DOI] [PubMed] [Google Scholar]
  2. Brandt P. W., Partridge J. B., Wattie W. J. Coronary arteriography; method of presentation of the arteriogram report and a scoring system. Clin Radiol. 1977 Jul;28(4):361–365. doi: 10.1016/s0009-9260(77)80140-2. [DOI] [PubMed] [Google Scholar]
  3. Erlebacher J. A., Weiss J. L., Eaton L. W., Kallman C., Weisfeldt M. L., Bulkley B. H. Late effects of acute infarct dilation on heart size: a two dimensional echocardiographic study. Am J Cardiol. 1982 Apr 1;49(5):1120–1126. doi: 10.1016/0002-9149(82)90035-2. [DOI] [PubMed] [Google Scholar]
  4. Grande P., Hansen B. F., Christiansen C., Naestoft J. Estimation of acute myocardial infarct size in man by serum CK-MB measurements. Circulation. 1982 Apr;65(4):756–764. doi: 10.1161/01.cir.65.4.756. [DOI] [PubMed] [Google Scholar]
  5. Hearse D. J., Yellon D. M. The "border zone" in evolving myocardial infarction: controversy or confusion? Am J Cardiol. 1981 Jun;47(6):1321–1334. doi: 10.1016/0002-9149(81)90266-6. [DOI] [PubMed] [Google Scholar]
  6. Kloner R. A., Fishbein M. C., Braunwald E., Maroko P. R. Effect of propranolol on mitochondrial morphology during acute myocardial ischemia. Am J Cardiol. 1978 May 1;41(5):880–886. doi: 10.1016/0002-9149(78)90728-2. [DOI] [PubMed] [Google Scholar]
  7. Kloner R. A., Fishbein M. C., Cotran R. S., Braunwald E., Maroko P. R. The effect of propranolol on microvascular injury in acute myocardial ischemia. Circulation. 1977 Jun;55(6):872–880. doi: 10.1161/01.cir.55.6.872. [DOI] [PubMed] [Google Scholar]
  8. Lee J. T., Ideker R. E., Reimer K. A. Myocardial infarct size and location in relation to the coronary vascular bed at risk in man. Circulation. 1981 Sep;64(3):526–534. doi: 10.1161/01.cir.64.3.526. [DOI] [PubMed] [Google Scholar]
  9. Maroko P. R., Kjekshus J. K., Sobel B. E., Watanabe T., Covell J. W., Ross J., Jr, Braunwald E. Factors influencing infarct size following experimental coronary artery occlusions. Circulation. 1971 Jan;43(1):67–82. doi: 10.1161/01.cir.43.1.67. [DOI] [PubMed] [Google Scholar]
  10. Miura M., Thomas R., Ganz W., Sokol T., Shell W. E., Toshimitsu T., Kwan A. C., Singh B. N. The effect of delay in propranolol administration on reduction of myocardial infarct size after experimental coronary artery occlusion in dogs. Circulation. 1979 Jun;59(6):1148–1157. doi: 10.1161/01.cir.59.6.1148. [DOI] [PubMed] [Google Scholar]
  11. Norris R. M., Barnaby P. F., Brown M. A., Geary G. G., Clarke E. D., Logan R. L., Sharpe D. N. Prevention of ventricular fibrillation during acute myocardial infarction by intravenous propranolol. Lancet. 1984 Oct 20;2(8408):883–886. doi: 10.1016/s0140-6736(84)90651-2. [DOI] [PubMed] [Google Scholar]
  12. Norris R. M., Sammel N. L., Clarke E. D., Brandt P. W. Treatment of acute myocardial infarction with propranolol. Further studies on enzyme appearance and subsequent left ventricular function in treated and control patients with developing infarcts. Br Heart J. 1980 Jun;43(6):617–622. doi: 10.1136/hrt.43.6.617. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Peter T., Norris R. M., Clarke E. D., Heng M. K., Singh B. N., Williams B., Howell D. R., Ambler P. K. Reduction of enzyme levels by propranolol after acute myocardial infarction. Circulation. 1978 Jun;57(6):1091–1095. doi: 10.1161/01.cir.57.6.1091. [DOI] [PubMed] [Google Scholar]
  14. Rasmussen M. M., Reimer K. A., Kloner R. A., Jennings R. B. Infarct size reduction by propranolol before and after coronary ligation in dogs. Circulation. 1977 Nov;56(5):794–798. doi: 10.1161/01.cir.56.5.794. [DOI] [PubMed] [Google Scholar]
  15. Reimer K. A., Lowe J. E., Rasmussen M. M., Jennings R. B. The wavefront phenomenon of ischemic cell death. 1. Myocardial infarct size vs duration of coronary occlusion in dogs. Circulation. 1977 Nov;56(5):786–794. doi: 10.1161/01.cir.56.5.786. [DOI] [PubMed] [Google Scholar]
  16. Reynolds R. D., Burmeister W. E., Gorczynski R. J., Dickerson D. D., Mathews M. P., Lee R. J. Effects of propranolol on myocardial infarct size with and without coronary artery reperfusion in the dog. Cardiovasc Res. 1981 Jul;15(7):411–420. doi: 10.1093/cvr/15.7.411. [DOI] [PubMed] [Google Scholar]
  17. Rogers W. J., McDaniel H. G., Smith L. R., Mantle J. A., Russel R. O., Jr, Rackley C. E. Correlation of angiographic estimates of myocardial infarct size and accumulated release of creatine kinase MB isoenzyme in man. Circulation. 1977 Aug;56(2):199–205. doi: 10.1161/01.cir.56.2.199. [DOI] [PubMed] [Google Scholar]
  18. Sabbah H. N., Marzilli M., Stein P. D. The relative role of subendocardium and subepicardium in left ventricular mechanics. Am J Physiol. 1981 Jun;240(6):H920–H926. doi: 10.1152/ajpheart.1981.240.6.H920. [DOI] [PubMed] [Google Scholar]
  19. Sammel N. L., Norris R. M., Hughes C. F., Johnson R. N., Ashton N. G., Elliott R. L. Severity of canine myocardial infarcts in relation to indices of oxygen demand: preservation of myocardial creatine kinase activity by vagal stimulation and propranolol. Cardiovasc Res. 1983 Jan;17(1):50–60. doi: 10.1093/cvr/17.1.50. [DOI] [PubMed] [Google Scholar]
  20. Sammel N. L., Stuckey J. G., Brandt P. W., Norris R. M. Comparison of enzymic with cineangiocardiographic estimations of myocardial infarct size. Br Heart J. 1980 Jun;43(6):609–616. doi: 10.1136/hrt.43.6.609. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Shatney C. H., MacCarter D. J., Lillehei R. C. Effects of allopurinol, propranolol and methylprednisolone on infarct size in experimental myocardial infarction. Am J Cardiol. 1976 Mar 31;37(4):572–580. doi: 10.1016/0002-9149(76)90398-2. [DOI] [PubMed] [Google Scholar]
  22. Vokonas P. S., Malsky P. M., Paul S. J., Robbins S. L., Hood W. B., Jr Radioautographic studies in experimental myocardial infarction: profiles of ischemic blood flow and quantification of infarct size in relation to magnitude of ischemic zone. Am J Cardiol. 1978 Jul;42(1):67–75. doi: 10.1016/0002-9149(78)90987-6. [DOI] [PubMed] [Google Scholar]
  23. Wickline S. A., McNamara J. J. Vectorcardiographic quantification of infarct size in baboons. Circulation. 1978 May;57(5):910–920. doi: 10.1161/01.cir.57.5.910. [DOI] [PubMed] [Google Scholar]

Articles from British Heart Journal are provided here courtesy of BMJ Publishing Group

RESOURCES